Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HealthCentral.com

This article was originally published in The Tan Sheet

Executive Summary

Online content and commerce presence acquires DrugEmporium.com in late July deal expanding HealthCentral's Rx and OTC base. Terms of the deal will provide Drug Emporium investors with stock convertible into 2.4 mil. common shares, HealthCentral said. Additionally, the company will acquire all aspects of the DrugEmporium.com Web site, rights to their 60,000-sq. ft. distribution and Rx fulfillment center and "at least $3 mil. in inventory." In March, HealthCentral.com acquired Vitamins.com, expanding its supplements base (1"The Tan Sheet" March 20, p. 14)

You may also be interested in...



HealthCentral Strives For More; Drugstore.com, PlanetRx Turn To Cuts

Visitors to e-health provider more.com are now being redirected to HealthCentral.com following the buyout by Emeryville, Calif.-based HealthCentral.

HealthCentral Strives For More; Drugstore.com, PlanetRx Turn To Cuts

Visitors to e-health provider more.com are now being redirected to HealthCentral.com following the buyout by Emeryville, Calif.-based HealthCentral.

HealthCentral.com Expands Supplement Presence With Vitamins.com Buy

HealthCentral.com's purchase of Vitamins.com expands the online healthcare content provider's dietary supplement/natural product offerings to more than 8,000. HealthCentral.com plans to issue $103.5 mil. in stock to Vitamins.com as part of the agreement.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel